Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Fulgent Genetics, |
RCV002478435 | SCV002780060 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-09-29 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000643505 | SCV000765192 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-11-19 | criteria provided, single submitter | clinical testing | |
| Laboratory for Molecular Medicine, |
RCV000152255 | SCV000201075 | uncertain significance | not specified | 2013-09-26 | criteria provided, single submitter | clinical testing | The Ile19222Thr variant in TTN has not been previously reported in individuals w ith cardiomyopathy or in larger population studies. Computational analyses (bio chemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) su ggest that this variant may not impact the normal function of the protein. Addi tional information is needed to fully assess the clinical significance of this v ariant. |